精神分裂症谱系障碍中抑郁症状的神经环路与治疗靶向
该研究分析三项研究共157例精神分裂症谱系障碍患者的数据,用偏最小二乘相关法识别出与抑郁和阴性症状相关的三个潜变量及对应功能连接模式;对重复经颅磁刺激试验数据(活性组37例、假刺激组33例)的二次分析显示,双侧背外侧前额叶活性重复经颅磁刺激降低一般抑郁症状,但不降低内疚相关或阴性症状。
要点
- 潜变量1将一般抑郁症状因子与默认网络、额顶网络和扣带-岛盖网络之间及网络内正相关连接相关联。
- 潜变量2将阴性症状(无抑郁症状)与额顶网络和扣带-岛盖网络等之间的负相关连接相关联。
- 活性(而非假)双侧背外侧前额叶重复经颅磁刺激降低一般抑郁症状,但不降低内疚相关或阴性症状。
核心结论
- 结果清晰区分了精神分裂症谱系障碍中抑郁症状与阴性症状的神经环路,并在抑郁的双因子结构上分离。
- 这些发现支持精神分裂症谱系障碍患者抑郁症状与阴性症状具有不同的神经生物学通路。
- 由于治疗选择目前有限,作者认为双侧背外侧前额叶重复经颅磁刺激值得针对精神分裂症谱系障碍患者的一般抑郁症状进一步探索。
研究设计与样本
- 分析三项研究的数据,共157例精神分裂症谱系障碍患者,包括两项神经影像研究和一项重复经颅磁刺激随机试验。
- 采用偏最小二乘相关法研究静息态功能连接与抑郁症状和阴性症状之间的关联。
- 对重复经颅磁刺激试验数据进行二次分析(活性组37例,假刺激组33例),评估偏最小二乘相关法得出的症状特征与治疗结局的关系。
主要发现
- 偏最小二乘相关法识别出三个潜变量,将功能脑环路与症状特征相关联。
- 潜变量1将一般抑郁症状因子与默认网络、额顶网络和扣带-岛盖网络之间及网络内的正相关连接相关联。
- 潜变量2将阴性症状(无抑郁症状)通过负相关连接相关联,尤其是额顶网络与扣带-岛盖网络之间,以及默认网络与额顶网络和扣带-岛盖网络之间。
- 潜变量3将内疚和早醒抑郁因子通过默认网络、额顶网络和扣带-岛盖网络的负相关而非正相关连接相关联。
- 次级视觉网络与一般抑郁症状呈正相关,与内疚和阴性症状呈负相关。
临床怎么用
- 原文未据此给出推荐。
- 作者认为,由于治疗选择目前有限,双侧背外侧前额叶重复经颅磁刺激值得针对精神分裂症谱系障碍患者的一般抑郁症状进一步探索。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Conceptual similarities between depressive and negative symptoms complicate biomarker and intervention development. This study employed a data-driven approach to delineate the neural circuitry underlying depressive and negative symptoms in schizophrenia spectrum disorders (SSDs). METHODS: Data from three studies were analyzed (157 participants with SSDs) to assess brain-behavior relationships: two neuroimaging studies and a randomized trial of repetitive transcranial magnetic stimulation (rTMS). Partial least squares correlation (PLSC) was used to investigate associations between resting-state functional connectivity and depressive and negative symptoms. Secondary analyses of rTMS trial data (active, N=37; sham, N=33) were used to assess relationships between PLSC-derived symptom profiles and treatment outcomes. RESULTS: PLSC identified three latent variables (LVs) relating functional brain circuitry with symptom profiles. LV1 related a general depressive symptom factor with positive associations between and within the default mode network (DMN), the frontoparietal network (FPN), and the cingulo-opercular network (CON). LV2 related negative symptoms (no depressive symptoms) via negative associations, especially between the FPN and the CON, but also between the DMN and the FPN and the CON. LV3 related a guilt and early wakening depression factor via negative rather than positive associations with the DMN, FPN, and CON. The secondary visual network had a positive association with general depressive symptoms and negative associations with guilt and negative symptoms. Active (but not sham) rTMS applied bilaterally to the dorsolateral prefrontal cortex (DLPFC) reduced general depressive but not guilt-related or negative symptoms. CONCLUSIONS: The results clearly differentiate the neural circuitry underlying depressive and negative symptoms, and segregated across the two-factor structure of depression in SSDs. These findings support divergent neurobiological pathways of depressive symptoms and negative symptoms in people with SSDs. As treatment options are currently limited, bilateral rTMS to the DLPFC is worth exploring further for general depressive symptoms in people with SSDs.
引用
- Gallucci J, Yu JC, Oliver LD, et al. Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders. Am J Psychiatry. 2024. PMID: 39350625. doi:10.1176/appi.ajp.20230655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。